lidocaine has been researched along with Amyotrophic Neuralgia in 5 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stav, A | 1 |
| Ovadia, L | 1 |
| Sternberg, A | 1 |
| Kaadan, M | 1 |
| Weksler, N | 1 |
| Dennert, R | 1 |
| Münzenberg, KJ | 1 |
| Haase, W | 1 |
| Palermo, S | 1 |
| Riello, R | 1 |
| Cammardella, MP | 1 |
| Carossino, D | 1 |
| Orlandini, G | 1 |
| Casigliani, R | 1 |
| Launo, C | 1 |
| Schopen, RD | 1 |
| Caminiti, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Do Cervical Interlaminar Epidural Steroid Injections With Low-dose Lidocaine Cause Transient Objective Upper Extremity Weakness? A Prospective Randomized Controlled Trial[NCT03127137] | Phase 4 | 123 participants (Actual) | Interventional | 2018-08-01 | Completed | ||
| Do Cervical Interlaminar Epidural Steroid Injections With Low-dose Lidocaine Cause Transient Objective Upper Extremity Weakness? A Prospective Randomized[NCT03382925] | Phase 4 | 16 participants (Actual) | Interventional | 2017-12-20 | Terminated (stopped due to Not enough cervical interlaminar patients who meet criteria in order to meet recruitment goals.) | ||
| A Prospective Randomized Comparative Trial of Targeted Injection Via a Transforaminal Approach With Dexamethasone Versus an Epidural Catheter Via an Interlaminar Approach With Particulate Steroid for the Treatment of Cervical Radicular Pain[NCT03382821] | Phase 4 | 120 participants (Actual) | Interventional | 2017-09-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Change in strength in both groups greater than or equal to 20% weakness in one or more myotomes 30 minutes after CESI using a hand held Dynamometer. (NCT03127137)
Timeframe: 30 minutes after the CESI procedure
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Yes, greater or equal to 20% weakness in greater or equal to 1 or more myotome | No, greater or equal to 20% weakness in greater or equal to 1 or more myotome | |
| Experimental Group 1 With Lidocaine | 25 | 35 |
| Experimental Group 2 With Saline | 30 | 30 |
The Percentage of Participants with Reduction of 50% or More of Neck and Arm Pain NRS score (NCT03382821)
Timeframe: 1 month follow up
| Intervention | percentage of participants (Number) |
|---|---|
| Transforaminal ESI With Dexamethasone | 49.1 |
| Interlaminar Catheter-targeted ESI With Triamcinolone | 68.5 |
"Patient Global Impression of Change is a scale which measures participant reported satisfaction after an intervention. The outcome was measured as the percent of patients reporting a PGIC score of 6-7 (indicating much improved and very much improved)" (NCT03382821)
Timeframe: 1 month, 3 month, 6 month, and 1 year follow up
| Intervention | percentage of participants (Number) | |||
|---|---|---|---|---|
| One month | Three months | Six months | One year | |
| Transforaminal Catheter-targeted ESI With Triamcinolone | 59 | 57 | 53 | 61 |
| Transforaminal ESI With Dexamethasone | 41 | 42 | 55 | 57 |
Percentage of patients with >30% improvement in Neck Disability Index-5 score. (NCT03382821)
Timeframe: 1 month, 3 month, 6 month, and 1 year follow up
| Intervention | percentage of participants (Number) | |||
|---|---|---|---|---|
| One month | Three month | Six month | One year | |
| Transforaminal Catheter-targeted ESI With Triamcinolone | 62 | 58 | 56 | 60 |
| Transforaminal ESI With Dexamethasone | 48 | 56 | 55 | 47 |
The Medication Quantification Scale (MQS) is an instrument used for clinical and research applications for quantifying medication regimen use in chronic pain populations. A 6.8 point reduction is considered equivalent to 10 morphine eqivalents. (NCT03382821)
Timeframe: 1 month, 3 month, 6 month, and 1 year follow up
| Intervention | percentage of participants (Number) | |||
|---|---|---|---|---|
| One month | Three month | Six month | One year | |
| Transforaminal Catheter-targeted ESI With Triamcinolone | 19 | 17 | 19 | 8 |
| Transforaminal ESI With Dexamethasone | 16 | 20 | 15 | 7 |
2 trials available for lidocaine and Amyotrophic Neuralgia
| Article | Year |
|---|---|
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
Cervical epidural steroid injection for cervicobrachialgia.
Topics: Adult; Aged; Analgesia, Epidural; Brachial Plexus Neuritis; Cervical Vertebrae; Chronic Disease; Dru | 1993 |
[Therapy of cervico-brachialgia. Controlled clinical comparison of a high-dose combination of neurotropic vitamins with an analgesic].
Topics: Adult; Brachial Plexus Neuritis; Clinical Trials as Topic; Drug Combinations; Female; Humans; Lidoca | 1976 |
3 other studies available for lidocaine and Amyotrophic Neuralgia
| Article | Year |
|---|---|
[TENS + mesotherapy association in the therapy of cervico-brachialgia: preliminary data].
Topics: Adult; Aged; Aged, 80 and over; Brachial Plexus Neuritis; Colchicine; Combined Modality Therapy; Dic | 1991 |
[Dexamonosone as a rheuma therapeutic agent].
Topics: Anti-Inflammatory Agents; Arm; Arthritis; Brachial Plexus Neuritis; Dosage Forms; Erythema Nodosum; | 1970 |
[Therapy of pain in cervicobrachialgia].
Topics: Autonomic Nerve Block; Brachial Plexus Neuritis; Cervical Plexus; Humans; Lidocaine; Stellate Gangli | 1966 |